Letter to: Real‐World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell‐Based Assay

Letter to: Real‐World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell‐Based Assay

Saved in:

Bibliographic Details
Main Author:	Adrian Budhram
Format:	Article
Language:	English
Published:	Wiley 2025-08-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.70062
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reply to Letter: Real‐World Clinical Experience With Serum MOG and AQP4 Antibody Testing by Live Versus Fixed Cell‐Based Assay
by: Yana Said, et al.
Published: (2025-08-01)

Real‐world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell‐based assay
by: Yana Said, et al.
Published: (2025-03-01)

Discontinuation of Immunotherapy in Patients With Relapsing Myelitis Without AQP4/MOG Antibodies
by: Ki Hoon Kim, et al.
Published: (2025-08-01)

Features of the diagnosis and treatment of patients with AQP-4-positive neuromyelitis optica and MOG antibody disease
by: V. E. Avdeeva, et al.
Published: (2021-11-01)

Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis
by: Sotaro Mori, et al.
Published: (2020-01-01)

Correction: Accuracy of the Fluorescence-Activated Cell Sorting Assay for the Aquaporin-4 Antibody (AQP4-Ab): Comparison with the Commercial AQP4-Ab Assay Kit.
by: Jiwon Yang, et al.
Published: (2017-01-01)

Clinical characteristics of patients with GFAP-IgG coexisting with AQP4-IgG or MOG-IgG
by: Qingchen Li, et al.
Published: (2025-07-01)

A rare case of systemic lupus erythematosus‐associated neuromyelitis optica spectrum disorder with cystic lesions and dual seropositivity for anti‐AQP4 and anti‐MOG antibodies
by: Omar Al Jassem, et al.
Published: (2024-09-01)

Understanding MOG antibody-associated disease in Brazil
by: Dagoberto Callegaro, et al.
Published: (2023-11-01)

Pediatric MOG antibody-positive encephalitis with normal brain magnetic resonance imaging: a new spectrum associated with MOG antibodies?
by: Yan Jiang, et al.
Published: (2025-02-01)

Unilateral optic neuritis associated with MOG antibodies in a pediatric patient
by: Danilo de Assis Pereira, et al.
Published: (2025-08-01)

Opposing Influences of Optic Neuritis and Transverse Myelitis on the Future Location of Relapses in MOG Antibody–Associated Disease
by: Daniel Lordelo San Martin, et al.
Published: (2025-03-01)

Anti-MOG syndrome: a road to be paved
by: Tarso Adoni

Selective Blockade of Two Aquaporin Channels, AQP3 and AQP9, Impairs Human Leukocyte Migration
by: Sabino Garra, et al.
Published: (2025-06-01)

The Clinical and Radiologic Features of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease (MOGAD) in the City of Sakarya, Türkiye
by: Saadet Sayan, et al.
Published: (2025-07-01)

Increased expression of AQP 1 and AQP 5 in rat lungs ventilated with low tidal volume is time dependent.
by: Gustavo Fabregat, et al.
Published: (2014-01-01)

A rapid real-time polymerase chain reaction-based live virus microneutralization assay for detection of neutralizing antibodies against SARS-CoV-2 in blood/serum.
by: Syed Hani Abidi, et al.
Published: (2021-01-01)

Letter Regarding “Comparison of 2 Assays for Measuring Serum Total Thyroxine Concentration in Dogs and Cats”
by: Matthew K. Wun
Published: (2025-05-01)

A clinical case with Anti-MOG associated demyelinating disease
by: D. A. Bazhenova, et al.
Published: (2025-08-01)

TRAGOM MOG DRUŽENJA S ANTOM GLAVIČIĆEM (Zabilješke iz dnevnika)
by: SREĆKO BOŽIČEVIĆ
Published: (2013-01-01)

MOG-IgG associated optic neuritis is not multiple sclerosis
by: Bruna Klein da Costa, et al.

Response to Letter Regarding “Comparison of 2 Assays for Measuring Serum Total Thyroxine Concentration in Dogs and Cats”
by: Ewan D. S. Wolff, et al.
Published: (2025-05-01)

Chronic central nervous system aspergillosis with coexisting GFAP and AQP4 antibody positivity: case report and literature review
by: Yimin Cao, et al.
Published: (2025-07-01)

P093: Adult presentation of MOGS-CDG: Expanding the clinical spectrum
by: Idris Wazeerud-din, et al.
Published: (2025-01-01)

Chaotic motion of charged test particles in a Kerr-MOG black hole with explicit symplectic algorithms
by: Zhenmeng Xu, et al.
Published: (2025-07-01)

A roadmap to increasing access to AQP4-Ig testing for NMOSD: expert recommendations
by: Raquel Vassão-Araujo, et al.
Published: (2025-02-01)

Case report: Overlapping syndrome of MOG-IgG associated optic neuritis and autoimmune encephalitis with co-existence of anti-NMDAR and anti-GABABR antibodies
by: Zhujun Mei, et al.
Published: (2025-01-01)

MOG-specific CAR Tregs: a novel approach to treat multiple sclerosis
by: Jihane Frikeche, et al.
Published: (2024-10-01)

AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
by: Diego Cardoso Fragoso, et al.
Published: (2023-06-01)

The Different Immune Response Between Onset and Remission of AQP4 Antibody-Positive Optic Neuritis Based on RNA Sequencing of Whole Blood
by: Shi R, et al.
Published: (2025-07-01)

In-depth immunochemical characterization of the serum antibody response using a dual-titration microspot assay
by: Ágnes Kovács, et al.
Published: (2025-02-01)

Comparison of diagnostic accuracy of microscopy and flow cytometry in evaluating N-methyl-D-aspartate receptor antibodies in serum using a live cell-based assay.
by: Melanie Ramberger, et al.
Published: (2015-01-01)

Diagnostic value of islet autoantibody assays practised in Russia. 1. Classic immunofluorescence islet cell antibody assay, immunoradiometric glutamic acid decarboxylase antibody assay, and ELISA tyrosine phosphatase antibody and insulin antibody assays
by: Alexei V. Timofeev, et al.
Published: (2016-11-01)

Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG Positive Patient
by: Sayed Hamid Mohseni, et al.
Published: (2018-01-01)

Efficacy and safety of tocilizumab treatment in refractory MOG-IgG related optic neuritis
by: Xintong Xu, et al.
Published: (2024-12-01)

MOG positive primary autoimmune meningitis mimicking tuberculous meningitis: a case series
by: Anand Kumar, et al.
Published: (2025-04-01)

The Serum Vancomycin Assay: A Test of Historic Interest
by: SD Shafran, et al.
Published: (1995-01-01)

Polydatin ameliorates hyperhidrosis by targeting Aqp5 in a mouse model
by: Jian-Feng Chen, et al.
Published: (2025-08-01)

Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGAD
by: Patrick Schindler, et al.
Published: (2025-07-01)

BEYOND THE WORLD REPUBLIC OF LETTERS
by: Myriam Avila
Published: (2018-06-01)